COVID-19: Wait for a novel drug or act with the age old drug – Do we have a choice?

• Pugazhenthan Thangaraju,
• Meenalotchini Prakash gurunthalingam,
• Sajitha venkatesan,
• Eswaran Thangaraju

Affiliations

Pugazhenthan Thangaraju

Corresponding author.; Department of Pharmacology, All India Institute of Medical Sciences, Raipur, India

Meenalotchini Prakash gurunthalingam

Department of Pharmacology, All India Institute of Medical Sciences, Raipur, India

Sajitha venkatesan

Department of Microbiology, All India Institute of Medical Sciences, Raipur, India

Eswaran Thangaraju

AKT Memorial College of Engineering and Technology, Kallakurichi, Tamil Nadu, India